Get the Stockscreener App
0.6295
5.78%
-0.0386
After Hours:
.63
0.0005
+0.08%
Rallybio Corp stock is traded at $0.6295, with a volume of 292.65K.
It is down -5.78% in the last 24 hours and up +11.44% over the past month.
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
See More
Previous Close:
$0.6681
Open:
$0.66
24h Volume:
292.65K
Relative Volume:
0.85
Market Cap:
$26.30M
Revenue:
-
Net Income/Loss:
$-74.56M
P/E Ratio:
-0.3437
EPS:
-1.8316
Net Cash Flow:
$-60.27M
1W Performance:
+1.84%
1M Performance:
+11.44%
6M Performance:
+98.58%
1Y Performance:
-38.28%
1-Day Range:
$0.6191
$0.672
1-Week Range:
$0.60
$0.72
52-Week Range:
$0.2201
$1.2401
Rallybio Corp Stock (RLYB) Company Profile
Name
Rallybio Corp
Sector
Industry
Phone
203- 859-3820
Address
234 CHURCH STREET, NEW HAVEN
Compare RLYB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RLYB
Rallybio Corp
|
0.6295 | 27.92M | 0 | -74.56M | -60.27M | -1.8316 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rallybio Corp Stock (RLYB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-15-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-07-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-17-23 | Initiated | H.C. Wainwright | Buy |
| Apr-10-23 | Initiated | Wedbush | Outperform |
| Dec-09-22 | Initiated | JP Morgan | Overweight |
| Feb-22-22 | Initiated | JMP Securities | Mkt Outperform |
| Aug-23-21 | Initiated | Cowen | Outperform |
| Aug-23-21 | Initiated | Evercore ISI | Outperform |
| Aug-23-21 | Initiated | Jefferies | Buy |
View All
Rallybio Corp Stock (RLYB) Latest News
Can Rallybio Corporation stock hit record highs againEntry Point & Free AI Powered Buy and Sell Recommendations - newser.com
Why retail investors favor Rallybio Corporation stockMarket Performance Summary & Verified Momentum Stock Alerts - newser.com
Will Rallybio Corporation continue its uptrendJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
How to monitor Rallybio Corporation with trend dashboardsJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Is Rallybio Corporation trending in predictive chart modelsQuarterly Market Summary & Daily Stock Trend Watchlist - newser.com
How Rallybio Corporation stock performs in rising dollar environmentJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Why Rallybio Corporation stock remains on buy listsBull Run & Verified Trade Idea Suggestions - newser.com
Technical signs of recovery in Rallybio CorporationJuly 2025 Price Swings & Verified Momentum Stock Watchlist - newser.com
How to build a custom watchlist for Rallybio CorporationMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Will Rallybio Corporation stock beat EPS estimatesGap Up & Stepwise Entry and Exit Trade Signals - newser.com
Is Rallybio Corporation stock reversal real or fakeWall Street Watch & Capital Efficient Trade Techniques - newser.com
Is Rallybio Corporation a candidate for recovery playJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
Using Ichimoku Cloud for Rallybio Corporation technicalsMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com
Rallybio’s RLYB116 Study: A Potential Game-Changer in Hematologic and Autoimmune Disease Treatment - TipRanks
Is Rallybio Corporation stock undervalued vs historical averagesMarket Performance Recap & Fast Entry and Exit Trade Plans - Fundação Cultural do Pará
Why Rallybio Corporation stock attracts global investors2025 Year in Review & Stepwise Entry and Exit Trade Signals - fcp.pa.gov.br
Rallybio Corp Stock (RLYB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):